Medicare Enrolled

Dr. Deepak Vadhan, M.D.

Pulmonary Disease · Brooklyn, NY
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
9920 4TH AVE, Brooklyn, NY 11209
7188364040
In practice since 2006 (19 years)
NPI: 1245314954 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Vadhan from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Vadhan? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Vadhan

Dr. Deepak Vadhan is a pulmonary disease specialist in Brooklyn, NY, with 19 years of NPI registration. Based on federal Medicare data, Dr. Vadhan performed 14,858 Medicare services across 1,910 unique beneficiaries.

Between the years covered by Open Payments, Dr. Vadhan received a total of $9,932 from 28 pharmaceutical and/or device companies across 479 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pulmonary disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Vadhan is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 1% volume in NY $9,932 industry payments

Medicare Practice Summary

Medicare Utilization ↗
14,858
Medicare services
Top 1% in NY for pulmonary disease
1,910
Unique beneficiaries
$15
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~782 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Allergy skin test
A diagnostic test performed to identify specific allergies by applying or introducing allergenic extracts to the body. The procedure measures the patient's immune response to various potential allergens.
12,502 $4 $15
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
585 $107 $175
Sleep study with heart rate and breathing monitoring
A sleep study that monitors heart rate, breathing patterns, and sleep duration. This test records physiological data while you sleep to assess your sleep quality and breathing function.
324 $140 $599
Spirometry test before and after medication
A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication.
197 $35 $147
Breathing device use evaluation
An assessment of how a patient uses a breathing device. The provider reviews the patient's technique and device handling.
185 $16 $50
Pulmonary gas exchange test
A test to examine how well the lungs exchange gases.
166 $55 $147
Lung volume test using gas dilution or washout
A test that measures the amount of air in your lungs by using a gas dilution or washout method.
159 $41 $100
Lung volume measurement test
A test that measures the largest amount of air you can breathe in and out. It evaluates the total capacity of your lungs.
146 $15 $100
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
135 $68 $150
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
105 $101 $218
Telephone medical discussion, 11-20 minutes
A phone conversation with a physician lasting between 11 and 20 minutes.
94 $67 $100
Intravenous infusion, 1 hour or less
Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less.
78 $60 $143
Obesity behavioral counseling, 15 minutes
A 15-minute face-to-face session focused on behavioral counseling to help manage obesity.
76 $30 $50
Telephone medical discussion, 21-30 minutes
A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone.
35 $104 $150
Exercise-induced lung stress test
A test performed to evaluate how the lungs function during physical exertion. It helps identify breathing difficulties or lung conditions that occur specifically when exercising.
33 $32 $150
Inhalation treatment for airway obstruction or sputum production
A treatment involving the inhalation of medication to help clear airway obstructions or reduce sputum production.
22 $9 $65
Smoking cessation counseling, 4-10 minutes
A brief counseling session focused on helping patients quit smoking and tobacco use. The provider spends 4 to 10 minutes discussing strategies and support for cessation.
16 $17 $53
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.5% high complexity
0.2% medium
99.3% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$9,932
Total received (2018-2024)
Avg $1,419/year across 7 years
Top 19% in NY for pulmonary disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
28
Companies
479
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$9,500 (95.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$433 (4.4%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,936
2023
$1,786
2022
$1,933
2021
$999
2020
$729
2019
$1,350
2018
$1,199

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$814
GlaxoSmithKline, LLC.
$419
Lilly USA, LLC
$191
Regeneron Healthcare Solutions, Inc.
$188
Boehringer Ingelheim Pharmaceuticals, Inc.
$88
GENZYME CORPORATION
$71
Amgen Inc.
$49
Paratek Pharmaceuticals, Inc.
$33
Philips North America LLC
$32
Mallinckrodt Hospital Products Inc.
$27
Insmed, Inc.
$22
Top 3 companies account for 73.6% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$2,789
GlaxoSmithKline, LLC.
$1,779
Boehringer Ingelheim Pharmaceuticals, Inc.
$1,463
Lilly USA, LLC
$548
Regeneron Healthcare Solutions, Inc.
$494
Mallinckrodt Enterprises LLC
$339
Electromed, Inc.
$326
Insmed, Inc.
$321
Amgen Inc.
$315
Genentech USA, Inc.
$253
Actelion Pharmaceuticals US, Inc.
$248
GENZYME CORPORATION
$132
ADVANCED RESPIRATORY, INC
$126
Advanced Respiratory, Inc
$106
Philips Electronics North America Corporation
$99
Paratek Pharmaceuticals, Inc.
$97
Mylan Specialty L.P.
$88
Circassia Pharmaceuticals Inc
$78
Mallinckrodt Hospital Products Inc.
$52
Sunovion Pharmaceuticals Inc.
$51
Mallinckrodt LLC
$51
Novo Nordisk Inc
$46
Philips North America LLC
$32
Merck Sharp & Dohme Corporation
$29
Grifols USA, LLC
$21
Janssen Pharmaceuticals, Inc
$19
Baxter Healthcare
$16
Teva Pharmaceuticals USA, Inc.
$11
Top 3 companies account for 60.7% of all-time payments
Associated products mentioned in payments ›
(8874) inCourage · (AK6) Vest Therapy · ACTHAR · AIRSUPRA · ANORO · ANORO ELLIPTA · AREXVY · Arikayce · BREO · BREZTRI · BREZTRI AEROSPHERE · CINQAIR · DUPIXENT · Esbriet · FARXIGA · FASENRA · Hillrom - Life 2000 Ventilation System · JANUVIA · LONHALA MAGNAIR · Life 2000 Ventilation System · MOUNJARO · NUCALA · NUZYRA · OFEV · OPSUMIT · Ozempic · Prolastin-C · Respiratoriy Care Undiv · SMARTVEST · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SYMBICORT · TEZSPIRE · TRADJENTA · TRELEGY ELLIPTA · TRULICITY · TUDORZA PRESSAIR · The Monarch Airway Clearance System · The Vest System Model 105 Home Care · Trilogy 100 · UPTRAVI · UTIBRON · Wellcentive Undiv · XARELTO · Xolair · YUPELRI · Yupelri
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (96%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a pulmonary disease specialist in Brooklyn?
Compare pulmonary diseases in the Brooklyn area by procedure volume, costs, and industry payment transparency.
Browse pulmonary diseases nearby

Geographic Context

Pulmonary diseases within 10 mi
639
Per 100K population
24.1
County median income
$78,548
Nearest hospital
VA NEW YORK HARBOR HEALTHCARE SYSTEM - BROOKLYN
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Vadhan is a mixed practice specialist, with above-average Medicare volume (top 1% in NY), with low-engagement industry engagement in the top 19% of NY peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Vadhan experienced with allergy skin test?
Based on Medicare claims data, Dr. Vadhan performed 12,502 allergy skin test services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Vadhan receive payments from pharmaceutical companies?
Yes. Dr. Vadhan received a total of $9,932 from 28 companies across 479 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Vadhan's costs compare to other pulmonary diseases in Brooklyn?
Dr. Vadhan's average Medicare payment per service is $15. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Vadhan) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →